Montalban X, et al. Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients With Primary Progressive Multiple Sclerosis in the ORATORIO Trial. PR2086. EAN 2017.
Intraveneuze trombolyse bij herseninfarct met ‘seizure at onset’
nov 2019 | Neuro-vasculair